These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17567459)

  • 1. Role of mitochondria in non-alcoholic fatty liver disease.
    Pessayre D
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents.
    Turner N; Bruce CR; Beale SM; Hoehn KL; So T; Rolph MS; Cooney GJ
    Diabetes; 2007 Aug; 56(8):2085-92. PubMed ID: 17519422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance.
    Raffaella C; Francesca B; Italia F; Marina P; Giovanna L; Susanna I
    Obesity (Silver Spring); 2008 May; 16(5):958-64. PubMed ID: 18277391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of oxidative stress in non-alcoholic steatohepatitis].
    Mitsuyoshi H; Itoh Y; Okanoue T
    Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.
    Pessayre D; Mansouri A; Fromenty B
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G193-9. PubMed ID: 11804839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial involvement in non-alcoholic steatohepatitis.
    Serviddio G; Sastre J; Bellanti F; Viña J; Vendemiale G; Altomare E
    Mol Aspects Med; 2008; 29(1-2):22-35. PubMed ID: 18061659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.
    Sanyal AJ; Campbell-Sargent C; Mirshahi F; Rizzo WB; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Clore JN
    Gastroenterology; 2001 Apr; 120(5):1183-92. PubMed ID: 11266382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
    Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
    Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and steatosis in humans.
    Capeau J
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial injury in steatohepatitis.
    Pessayre D; Fromenty B; Mansouri A
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1095-105. PubMed ID: 15489566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional lipid-induced oxidative stress leads to mitochondrial dysfunction followed by necrotic death in FaO hepatocytes.
    Tirosh O; Ilan E; Anavi S; Ramadori G; Madar Z
    Nutrition; 2009 Feb; 25(2):200-8. PubMed ID: 18947977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha.
    Ramirez-Tortosa MC; Ramirez-Tortosa CL; Mesa MD; Granados S; Gil A; Quiles JL
    Free Radic Biol Med; 2009 Oct; 47(7):924-31. PubMed ID: 19539747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways.
    Manna P; Sinha M; Sil PC
    Toxicology; 2009 Mar; 257(1-2):53-63. PubMed ID: 19133311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates.
    Larosche I; Choumar A; Fromenty B; Lettéron P; Abbey-Toby A; Van Remmen H; Epstein CJ; Richardson A; Feldmann G; Pessayre D; Mansouri A
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):326-38. PubMed ID: 19063909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
    Serviddio G; Bellanti F; Vendemiale G; Altomare E
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
    Rolo AP; Teodoro JS; Palmeira CM
    Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
    Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
    Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(2):377-9. PubMed ID: 15922116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN; Tao RY; Tian JY; Liu GT; Ye F
    Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model.
    Serviddio G; Bellanti F; Tamborra R; Rollo T; Romano AD; Giudetti AM; Capitanio N; Petrella A; Vendemiale G; Altomare E
    Eur J Clin Invest; 2008 Apr; 38(4):245-52. PubMed ID: 18339004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.